Gilead Sciences Inc (GILD): Today's Featured Health Care Laggard

Gilead (GILD) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 0.9%. By the end of trading, Gilead fell 68 cents (-1.3%) to $53.08 on average volume. Throughout the day, 5.9 million shares of Gilead exchanged hands as compared to its average daily volume of 5.4 million shares. The stock ranged in price between $53.03-$54 after having opened the day at $53.68 as compared to the previous trading day's close of $53.76. Other company's within the Health Care sector that declined today were: Staar Surgical (STAA), down 25.7%, Somaxon Pharmaceuticals (SOMX), down 13%, pSivida (PSDV), down 12%, and Novavax (NVAX), down 10.8%.

• ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases worldwide. Gilead has a market cap of $40.25 billion and is part of the drugs industry. The company has a P/E ratio of 16, above the average drugs industry P/E ratio of 15.9 and below the S&P 500 P/E ratio of 17.7. Shares are up 31.3% year to date as of the close of trading on Thursday. Currently there are 19 analysts that rate Gilead a buy, no analysts rate it a sell, and three rate it a hold.

TheStreet Ratings rates Gilead as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, solid stock price performance, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

• You can view the full Gilead Ratings Report.

On the positive front, Aoxing Pharmaceutical Company (AXN), up 24%, Astex Pharmaceuticals (ASTX), up 13.5%, Durect Corporation (DRRX), up 12.6%, and Onyx Pharmaceuticals (ONXX), up 11.7%, were all gainers within the health care sector with Medivation (MDVN) being today's featured health care sector leader.

• Use our health care section to find sector-relevant news.
• Or find some new ideas from our top rated stocks lists.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR (XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care (RXD).

• Find other investment ideas from our top rated ETFs lists.

 

For more information on Gilead Sciences Inc click any of the following:

• Gilead Sciences Inc Stock Price

• Gilead Sciences Inc Analyst Ratings

• Gilead Sciences Inc Key Stats & Profile

• Gilead Sciences Inc Earnings

• Gilead Sciences Inc Ratio Comparison

• Gilead Sciences Inc Growth Rates

• Gilead Sciences Inc Balance Sheet

• Gilead Sciences Inc Cash Flow

• Gilead Sciences Inc Income Statement